50 Deep Tech Startups in Cambridge to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Human microbiome therapeutics developer creating live bacterial treatments and biomarkers. |
$66M | Seventure Partners, Cambridge Innovation Capital | 11 to 50 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@microbiotica.com | |
Transforming mental healthcare by unlocking the power of clinical data |
$52M · Series B | Molten Ventures | 101 to 250 | Health Tech, Deep Tech | B2B, B2C | Cambridge, UK | •••••••••••@iesogroup.com | |
Platform for understanding and defining the biological codes that make up human cells. |
$41M · Series A | Metaplanet Holdings, BlueYard Capital | 101 to 250 | Health Tech, Biotech, Deep Tech, Business Intelligence | B2B | Cambridge, UK | •••••••••••@bit.bio | |
"Biotechnology platform producing sugar substitutes." |
$24M | Khosla Ventures, Felicis Ventures, Y Combinator | 11 to 50 | Health Tech, Foodtech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@supplant.com | |
Desktop technology making biology accessible by synthesizing proteins and genes. |
$42M · Series B | Future Planet Capital, Amadeus Capital, Verve Ventures | 11 to 50 | Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@nuclera.com | |
Contract Research Organization specializing in bioscience research services. |
$4M · Series A | Gresham House Ventures, NPIF Maven Equity Finance | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@metrionbiosciences.com | ||
Platform enabling the development of cell therapies through advanced reprogramming techniques. |
$10M · Series A | Astellas Venture Management, Parkwalk Advisors, Ahren Innovation Capital | 101 to 250 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@mogrify.co.uk | |
Fibroblast technology designed to develop new therapies for diseases. |
$11M · Seed | GV, Forbion Capital Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@mestagtx.com | |
Cancer immunotherapeutics company working across the Atlantic. |
$13M · Seed | Cambridge Innovation Capital | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@epitopea.com | |
Pet therapeutics startup dedicated to developing medicines for pets. |
$13M · Series A | Cambridge Innovation Capital, Parkwalk Advisors | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@petmedix.co.uk | |
Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications. |
$5M · Series B | Parkwalk Advisors, Downing Ventures | 11 to 50 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@qkine.com | ||
Cancer diagnostics. |
$16M · Series A | Business Growth Fund | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@cyted.ai | ||
Supplier of configurable process node agnostic analog IP building blocks. |
$5M · Seed | Omers Ventures, Firstminute Capital, MMC Ventures | 11 to 50 | Deep Tech, Manufacturing, Semiconductor | B2B | Cambridge, UK | •••••••••••@agileanalog.com | |
Independent biotech company focused on developing new cancer therapies targeting DNA damage response. |
$152M · Series C | 101 to 250 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@artiospharma.com | |||
Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw. |
$88M · Series D | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@cambridge-epigenetix.com | |||
Platform specializing in single cell analysis and characterization, offering related R&D services. |
$4M | Sofinnova Partners | 11 to 50 | Health Tech, Deep Tech | B2B | Cambridge, UK | •••••••••••@spherefluidics.com | |
Novel cancer therapies. |
$30M · Series B | 11 to 50 | Health Tech, Deep Tech | B2C | Cambridge, UK | •••••••••••@stormtherapeutics.com | ||
Drug discovery company based in Cambridge, UK. |
$45M · Series B | 1 to 10 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@phoremost.com | |||
Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis. |
$7M · Series A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@predictimmune.com | |||
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery. |
$1M · Pre Seed | 1 to 10 | Health Tech, AI, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@cardiatec.ai | ||
Treatment for patients with chronic wounds. |
$13M · Series B | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@solascure.com | |||
Platform for increasing protein production in the body using specialized translation enhancers. |
$12M · Seed | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@transinetx.com | ||
Biopharmaceutical company focused on drug discovery and development for protein misfolding diseases. |
$16M | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@wrentherapeutics.com | |||
Platform technology overcoming antibacterial resistance. |
$9M | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@phicotx.co.uk | |||
Platform identifying chemical starting points to speed up drug discovery at lower costs. |
$2M · Seed | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@pharmenable.com | ||
Platform for life science professionals to connect with global experts for strategic engagement. |
$3M | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@monocl.com | ||
Biotechnology company focused on targeting deubiquitinase enzymes for cancer therapy. |
N/A | 1 to 10 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@cellcentric.com | |||
Drug discovery company focusing on developing bone morphogenetic proteins since 2015. |
N/A | 1 to 10 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@morphogen-ix.com | |||
Molecular therapies for cancer patients. |
N/A | 11 to 50 | Health Tech, Deep Tech | B2C | Cambridge, UK | •••••••••••@acaciapharma.com | ||
Supplier of protein research tools for scientific studies. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@antibodies.com | |||
A multi-disciplinary team, based in Cambridge, working to solve some of the most difficult problems in biotechnology. |
N/A | 11 to 50 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@base4.co.uk | |||
Platform for creating next-generation biotherapeutics. |
N/A | 101 to 250 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@bicycletherapeutics.com | |||
Platform offering precision oncology solutions to improve cancer treatment. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@ccg.ai | |||
Platform for developing proprietary drugs using VH antibody fragments. |
N/A | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@crescendobiologics.com | |||
Technology that advances genomics through innovative NGS techniques. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@csgenetics.com | |||
Human cell provider for drug discovery use in lead optimization and toxicity programs. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@definigen.com | |||
Technology for accelerating vaccine development and achieving significant improvements. |
N/A | 11 to 50 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@diosvax.com | |||
Produce pure, mature and highly consistent batches of human cell types for research, toxicology and drug development. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@elpis.ltd | |||
Biotech firm specializing in alternative splicing of VEGF for eye disease treatments. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@exonate.com | |||
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. |
N/A | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@f-star.com | |||
Software platform designed for urban mobility solutions in public transport within complex city environments. |
N/A | 101 to 250 | Deep Tech, Data and Analytics | Cambridge, UK | •••••••••••@five.ai | |||
Tools that revolutionize how proteins are characterized. |
N/A | 11 to 50 | Deep Tech | Cambridge, UK | •••••••••••@fluidic.com | |||
Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health. |
N/A | 251 to 500 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@horizondiscovery.com | |||
Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products. |
N/A | 1 to 10 | Deep Tech | Cambridge, UK | •••••••••••@lightcastdiscovery.co.uk | |||
An innovator in life science reagents and tools serving life science researchers globally to achieve their mission, faster. |
N/A | 1001 to 5000 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@abcam.com | |||
Biopharmaceutical developer creating innovative treatments for microbial infections. |
N/A | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@nemesisbio.com | ||||
Platform for reducing costs and improving the efficiency of genomics data processing. |
N/A | 1 to 10 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@petagene.com | |||
Platform developing innovative drugs for cancer treatment. |
N/A | 1 to 10 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@polyprox.com | |||
Therapies designed to achieve long-term disease remission with less frequent doses. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@revolobio.com | |||
Platform that enhances images by using patented Image Fusion technology and Deep Learning to reveal more color, detail, and clarity. |
N/A | 11 to 50 | Deep Tech, Data and Analytics | Cambridge, UK | •••••••••••@spectraledge.co.uk |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.